"LUNCHEON WITH THE EXPERTS"

With Dr. J. Randolph Hecht

No registration needed.

Date: Aug 27, 2026

Time: Noon Eastern (9 AM Pacific)

Here are the viewing options on Thursday, August 27th, at Noon Eastern (9 AM Pacific):

The Webinar will be live on Facebook Live (under Events) and YouTube Live.

Drop your questions for Dr. Hecht to answer in the comments on Facebook or chat on YouTube.

“Luncheon With The Experts” is a recurring educational outreach series (previously hosted by the Carcinoid Cancer Foundation) aimed at patients, caregivers, and the broader neuroendocrine cancer community. The sessions are hosted by Rain Bennett.

The series features medical specialists — oncologists, surgeons, researchers, and other clinical experts — who specialize in topics relevant to neuroendocrine cancer and answer audience questions live via chat.

Programs are typically delivered live (over Facebook Live and YouTube Live) at noon Eastern Time, allowing participants to join during their lunch break.

Live sessions are recorded and will be available afterward.

ABOUT J. RANDOLPH (RANDY) HECHT, MD

Gastrointestinal Medical Oncologist

UCLA Health

J. Randolph (Randy) Hecht, MD is a Professor of Clinical Medicine in the David Geffen School of Medicine at UCLA School of Medicine. He holds the Carol and Saul Rosenzweig Chair for Cancer Therapies Development and is the Director of the UCLA Gastrointestinal Oncology Program. He graduated from Eastern Virginia Medical School and took his internal medicine residency at Northwestern and completed fellowships in gastroenterology research at the University of Chicago, and in gastroenterology and medical oncology at UCLA. He is the director of the UCLA GI Oncology Program which has one of the largest clinical and research programs in the Western United States.

Dr. Hecht is an internationally known clinical and translational researcher who has published widely in the field of gastrointestinal cancers. He has run multiple phase II and phase III trials with targeted therapies and immunotherapy. Dr. Hecht is currently leading national and international multicenter trials with novel immune and CAR-T therapies. 

Dr. Hecht has a longstanding interest in caring for neuroendocrine tumor patients and runs the multidisciplinary GI NET Clinical Conference. Dr. Randy Hecht is the Medical Director of the University of California Los Angeles (UCLA) GI Neuroendocrine Tumor Program. UCLA is one of the largest major centers for the treatment of neuroendocrine tumors in the western US. He has been the institutional principal investigator for multiple trials in neuroendocrine tumors including studies with novel somatostatin analogues, small molecules, DLL3 directed therapies and immunotherapies as well as the UC Pancreatic Neuroendocrine Neoplasm observational trial. 

Dr. Hecht works closely with his colleagues in nuclear medicine and has been the medical principal investigator for nuclear medicine trials with lutetium-177 and actinium-225 based therapies. He is also on the medical advisory council of the Neuroendocrine Cancer Foundation, one of the largest NET patient advocacy groups in the world, and serves on the Steering Committee for the development of the NANETS clinical practice guidelines on “Systemic Therapies for Midgut Neuroendocrine Tumors.”

HOST

The sessions are hosted by Rain Bennett, a two-time Emmy-nominated filmmaker, author, and experienced host who produces and leads live conversations on behalf of the Neuroendocrine Cancer Foundation. Bennett has been involved with the neuroendocrine cancer community as a longtime filmmaker and supporter, using his storytelling and interview skills to bring expert perspectives to patients and caregivers.

 THANKS TO OUR SPONSORS

The opinions expressed by the guest presenters, as well as the questions asked by the audience, have not been created or suggested by NCF or the sponsors of this program. NCF does not endorse or promote any of the views, opinions or information provided in this presentation. Audience members should not rely solely on the opinions or information expressed by the guest presenter and should seek guidance and direction from their own medical advisors regarding any choices they make about their health or treatments.